Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
679.00    -5.00 (-0.73%)
Bid:
678.00
Ask:
680.00
Spread: 2.00 (0.295%)
Market Cap: £1.25b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Acquisition Share Incentive Awards and TVR

13 Jul 2021 07:00

RNS Number : 9968E
Volex PLC
13 July 2021
 

13 July 2021

Volex plc

("Volex" or the "Company")

Acquisition Share Incentive Awards and TVR

Further to the announcements dated 30 July 2019 and 2 March 2020 regarding the acquisition of Servatron, Inc ("Servatron"), Volex plc (AIM:VLX) is pleased to confirm that Servatron has exceeded the operating profit targets for the year ended 31 December 2020. As a result, under the acquisition retention award scheme agreed as part of that acquisition, 1,000,000 ordinary shares of 25 pence each ("Ordinary Shares") are due to former owners and senior employees of Servatron. Additionally, the second tranche of the deferred consideration of $1.73m due to the former owners and senior employees of Servatron has also been paid.

In addition, further to the announcement on 11 December 2018 regarding the acquisition of GTK (Holdco) Limited ("GTK"), Volex is pleased to announce that GTK has exceeded the operating profit targets for the third consecutive financial period. As a result, under the acquisition retention award scheme agreed as part of that acquisition, 666,668 Ordinary Shares are due to the former owners and senior managers of GTK.

The Volex board has, therefore, approved the issue of 1,666,668 Ordinary Shares to satisfy the vesting of the share awards granted to the senior employees and/or former owners of Servatron and GTK.

Application will be made to the London Stock Exchange for the new Ordinary Shares to be admitted to AIM, with the admission date expected to be 16 July 2021. On admission, the new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares of the Company. The Company's total issued share capital following admission will consist of 158,718,709 Ordinary Shares of 25 pence each with one voting right per share. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.

For further information please contact:

Volex plc

+44 (0)7971 1 56 431

Nat Rothschild, Executive Chairman

 

Jon Boaden, Chief Financial Officer

 

Christian Bedford, Group General Counsel & Company Secretary

 

 

Singer Capital Markets - Nominated Adviser & Joint Broker

+44 (0)20 7496 3000

Shaun Dobson

 

Iqra Amin

 

James Fischer

 

 

HSBC Bank Plc - Joint Broker

+44 (0)20 7991 8888

Simon Alexander

 

Joe Weaving

 

 

Powerscourt - Media Enquiries

+44 (0)20 7250 1446

James White

 

Jack Holden 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUUSURAUUBAUR
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.